Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease

Journal of Neurogenetics

Volumn 26, Issue 2, 2012, Pages 245-251

  Maeda, Toyoki ^a   Guan, Jing Zhi ^b   Koyanagi, Masamichi ^a   Higuchi, Yoshihiro ^a   Makino, Naoki ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b 309TH HOSPITAL OF PLA   (China)

Author keywords

DNA methylation; Parkinson's disease; subtelomere; telomere

Indexed keywords

DNA;

ADULT; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA METHYLATION; FEMALE; HUMAN; JAPANESE; LEUKOCYTE; MENTAL STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TELOMERE HOMEOSTASIS;

AGING; ANALYSIS OF VARIANCE; FEMALE; HUMANS; JAPAN; MIDDLE AGED; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TELOMERE; TELOMERE SHORTENING; TELOMERE-BINDING PROTEINS;

EID: 84863876804     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2011.651665     Document Type: Article

References (34)

1. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992). Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A, 89, 10114-10118.
2. Beal, M. F. (1995). Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol, 38, 357-366.
3. Beal, M. F. (2003). Mitochondria, oxidative damage, and in flammation in Parkinson's disease. Ann N Y Acad Sci, 991, 120-131.
4. Blackburn, E. H. (1991). Structure and function of telomeres. Nature, 350, 569-573.
5. Benetti, R., Garc í a-Cao, M., & Blasco, M. A. (2007). Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet, 39, 243-250.
6. Dei Cas, A., Spigoni, V., Franzini, L., Preti, M., Ardig ò, D., Derlindati, E., Metra, M., Monti, L. D, Dell'era, P., Gnudi, L., & Zavaroni, I. (2011). Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults. Nutr Metab Cardiovasc Dis, 2011 Aug 6. [Epub ahead of print]
7. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, et al. (2004). Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A, 101, 17312-17315. (Pubitemid 39627816)
8. Franco, R., Schoneveld, O., Georgakilas A. G., & Panayiotidis, M. I. (2008). Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett, 266, 6-11.
9. Gao, H. M., Liu, B., Zhang, W., & Hong, J. S. (2003). Novel anti-in flammatory therapy for Parkinson's disease. Trends Pharmacol Sci, 24, 395-401. (Pubitemid 36952555)
10. Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, et al. (1999). The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A., 96, 14412-14417. (Pubitemid 30000664)
11. Harley, C. B., Futcher, A. B., & Greider, C. W. (1990). Telomeres shorten during ageing of human fibroblasts. Nature, 345, 458-460.
12. Hepburn, P. A., Margison, G. P., & Tisdale M. J. (1991). Enzymatic methylation of cytosine in DNA is prevented by adjacent O6-methylguanine residues. J Biol Chem, 266, 7985-7987.
13. Hirsch, E. C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., & Michel, PP. (2003). The role of glial reaction and in flammation in Parkinson's disease. Ann N Y Acad Sci, 991, 214-228. (Pubitemid 36793816)
14. Insel, K. C., Merkle, C. J., Hsiao, C. P., Vidrine, A. N., &Montgomery, D. W. (2011). Biomarkers for cognitive aging-Part I: Telomere length, blood pressure and cognition among individuals with hypertension. Biol Res Nurs, 2011 May 17. [Epub ahead of print]
15. Iwama H, Ohyashiki K, Ohyashiki JH, Hayashi S, Yahata N, Ando K, et al. (1998). Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals. Hum Genet, 102, 397-402. (Pubitemid 28203979)
16. Joseph, J. A., Denisova, N., Fisher, D., Bickford, P., Prior, R., &Cao, G. (1998). Age-related neurodegeneration and oxidative stress: Putative nutritional intervention. Neurol Clin, 16, 747-755. (Pubitemid 28408984)
17. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, Miura K, et al. (1987). Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature, 327, 77-79. (Pubitemid 17063762)
18. Maeda, T., Guan, J. Z., Oyama, J., Higuchi, Y., & Makino, N. (2009). Age-related changes in subtelomeric methylation in the normal Japanese population. J Gerontol A Biol Sci Med Sci, 64, 426-434 .
19. McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001). Inflammation in Parkinson' s disease. Adv Neurol, 86, 83-89.
20. Migliore L, Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Scarpato R, et al. (2002). Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology, 58, 1809-1815. (Pubitemid 34663582)
21. Okuda K, Khan MY, Skurnick J, Kimura M, Aviv H, Aviv A. (2000). Telomere attrition of the human abdominal aorta: Relationships with age and atherosclerosis. Atherosclerosis, 152, 391-398.
22. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, et al. (2003). Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging, 24, 77-84. (Pubitemid 35454145)
23. Petrozzi L, Lucetti C, Gambaccini G, Bernardini S, Del Dotto P, Migliore L., et al. (2001). Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci, 22, 83-84. (Pubitemid 33622093)
24. Turk, P. W., Laayoun, A., Smith, S. S., & Weitzman, S. A. (1995). DNA adduct 8-hydroxyl-2 ¢ -deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis, 16, 1253-1255.
25. Turk, P. W., & Weitzman, S. A. (1995). Free radical DNA adduct 8-OH-deoxyguanosine affects activity of HPA II and MSP I restriction endonucleases. Free Radic Res, 23, 255-258.
26. Uziel O, Singer JA, Danicek V, Sahar G, Berkov E, Luchansky M., et al. (2007). Telomere dynamics in arteries and mononuclear cells of diabetic patients: Effect of diabetes and of glycemic control. Exp Gerontol. 42, 971-978. (Pubitemid 47432738)
27. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF., et al. (2005). Obesity, cigarette smoking, and telomere length in women. Lancet, 366, 662-664. (Pubitemid 41176019)
28. Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R., et al. (1993). Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes, age groups. Am J Hum Genet, 52, 661-667. (Pubitemid 23310132)
29. Vitte, J., Michel, B. F., Bongrand, P., & Gastaut, J. L. (2004). Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases. J Clin Immunol, 24, 683-692. (Pubitemid 40933120)
30. Wachsman, J. T. (1997). DNA methylation and the association between genetic and epigenetic changes: Relation to carcinogenesis. Mutat. Res, 375, 1-8.
31. Weitzman, S. A., Turk, P. W., Milkowski, D. H., & Kozlowski, K. (1994). Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci U S A, 91, 1261-1264. (Pubitemid 24058990)
32. Xiao, W., & Samson, L. (1993). In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc Natl Acad Sci U S A, 90, 2117-2121. (Pubitemid 23078576)
33. Yehezkel, S., Segev, Y., Viegas-Pe'quignot, E., Skorecki, K., & Selig, K. (2008). Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet, 17, 2776-2789.
34. Zakian, V. A. (1995). Telomeres: Beginning to understand the end. Science, 270, 1601-1607.